6307-82-0

Basic information

• Product Name: Methyl 2-chloro-5-nitrobenzoate
• Synonyms: 2-chloro-5-nitro-benzoicacimethylester;RARECHEM AL BF 0191;METHYL 2-CHLORO-5-NITROBENZENECARBOXYLATE;METHYL 2-CHLORO-5-NITROBENZOATE;2-CHLORO-5-NITROBENZOIC ACID METHYL ESTER;methylester kyseliny 2-chlor-5-nitrobenzoove;2-Chloro-5-nitrobenzoic acid methyl;5-Nitro-2-chlorobenzoic acid methyl
• CAS NO: 6307-82-0
• Molecular Formula: C₈H₆ClNO₄
• Molecular Weight: 215.59
• Product Categories: Aromatic Esters;Benzoic acid;Acids & Esters;Chlorine Compounds;Nitro Compounds;C8 to C9;Carbonyl Compounds;Esters
• Mol File: 6307-82-0.mol
• Article Data: 16

Chemical Properties

• Melting Point: 69-73 °C(lit.)
• Boiling Point: 316.7 °C at 760 mmHg
• Flash Point: 145.3 °C
• Appearance: Cream/Crystalline Powder
• Density: 1.4928 (rough estimate)
• Vapor Pressure: 0.000404mmHg at 25°C
• Refractive Index: 1.6000 (estimate)
• Water Solubility: Soluble in methanol. Insoluble in water.
• CAS DataBase Reference: Methyl 2-chloro-5-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-chloro-5-nitrobenzoate(6307-82-0)
• EPA Substance Registry System: Methyl 2-chloro-5-nitrobenzoate(6307-82-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 2
• RTECS: DG5426500
• HazardClass: IRRITANT
• Hazardous Substances Data: 6307-82-0(Hazardous Substances Data)

Usage

Uses

Methyl 2-chloro-5-nitrobenzoate is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff.

InChI:InChI=1/C8H6ClNO4/c1-14-8(11)6-4-5(10(12)13)2-3-7(6)9/h2-4H,1H3

Upstream product

• 186581-53-3 diazomethane 
• 2516-96-3 2-chloro-5-nitrobenzoic acid 
• 67-56-1 methanol 
• 610-96-8 methyl chlorobenzoate 
• 7697-37-2 nitric acid 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 54253-05-3 2-chloro-N-(4-chlorophenyl)-5-nitrobenzamide 
• 25784-91-2 2-chloro-5-nitrobenzoylchloride 
• 118-91-2 ortho-chlorobenzoic acid 
• 95-51-2 o-chloroaniline 
• 873-32-5 2-Chlorobenzonitrile 

Downstream Products

• 60042-00-4 2-anilino-5-nitro-benzoic acid methyl ester 
• 83909-55-1 methyl 2-(N-morpholino)-5-nitrobenzoate 
• 87370-87-4 2,4,6-Tripyrrolidino-2'-(methoxycarbonyl)-4'-nitrobiphenyl 
• 85695-19-8 2-(3-Methanesulfonyl-2-oxo-imidazolidin-1-yl)-5-nitro-benzoic acid methyl ester 
• 2965-22-2 methyl 2-fluoro-5-nitro-benzoate 
• 70290-38-9 2-(methylthio)-5-nitrobenzoic acid 
• 52040-87-6 2-(2,4-Dibrom-6-methylphenoxy)-5-nitrobenzoesaeuremethylester 
• 42122-75-8 methyl 2-chloro-5-aminobenzoate 
• 346704-90-3 methyl 5-nitro-2-phenoxy-benzoate 
• 346704-91-4 methyl 5-amino-2-phenoxybenzoate 
• 1174399-01-9 2-chloro-α,α'-dideuterio-5-nitrobenzyl alcohol 
• 1630042-67-9 N-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-6-nitroquinazolin-4-amine 

Relevant articles and documents

Development of 2-Morpholino-N-hydroxybenzamides as anti-proliferative PC-PLC inhibitors

Phosphatidylcholine-specific phospholipase C (PC-PLC) is a key enzyme involved in the metabolism of the mammalian phospholipid phosphatidylcholine into secondary messengers diacylglycerol (DAG) and phosphocholine. DAG and phosphocholine have been identifi

Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors

Phospholipases are enzymes that are involved in the hydrolysis of acyl and phosphate esters of phospholipids, generating secondary messengers that have implications in various cellular processes including proliferation, differentiation and motility. As such inhibitors of phospholipases have been widely studied for their use as anti-cancer therapeutics. Phosphatidylcholine-specific phospholipase C (PC-PLC) is implicated in the progression of a number of cancer cell lines including aggressing triple-negative breast cancers. Most current studies on PC-PLC have utilised D609 as the standard inhibitor however it is known to have multiple failings, including poor stability in aqueous media. 2-Morpholinobenzoic acids were recently identified using vHTS as a potential class of lead compounds, with improvements over D609. In this work 129 analogues in this class were prepared and their PC-PLC inhibitory activity was assessed. It was found that the majority of these novel compounds had improved activity when compared to D609 with the most potent inhibitors completely inhibiting enzyme activity. It was determined that the best compound/s contained a morpholino and 2-substituted N-benzyl moieties with these findings explained using molecular modelling. The compounds reported here will allow for improved study of PC-PLC activity.

Acylhydrazone compounds with anti-tumor activity as well as preparation method and application of acylhydrazone compounds

The invention belongs to the technical field of medicinal chemistry, and in particular relates to acylhydrazone compounds with anti-tumor activity as well as a preparation method and application of the acylhydrazone compounds. The structures of the acylhydrazone compounds are as shown in a general formula (I) shown in the description, wherein R and R' are independently selected from any one or more of halogen, amino, cyano, alkoxy, 3,4-methylenedioxy, nitro, phenyl or substituted phenyl, and R and R' substituents are mono-substituted, disubstituted or tri-substituted. The preparation method issimple; biological activity test results of the compounds show that the compounds have a very good inhibitory effect on histone methyltransferase SET7, and have good application prospect in the development of anti-tumor aspects.